Core Insights - Bureau Veritas reported robust revenue performance in Q3 2025, with total revenue of EUR 1,583.7 million, reflecting a 2.3% year-on-year increase and a strong organic growth of 6.3% [10][8][11] - The company reaffirmed its full-year 2025 outlook, supported by a solid backlog and a strong opportunities pipeline, with an organic growth rate of 6.6% for the first nine months of the year [4][5][21] - The LEAP | 28 strategy continues to drive the company's growth, with targeted acquisitions contributing to revenue and expanding capabilities in key sectors [6][14] Q3 2025 Key Figures - Revenue of EUR 1,583.7 million, up 2.3% year-on-year and up 6.3% organically [10][8] - Organic growth rates by segment: Marine & Offshore (+16.2%), Buildings & Infrastructure (+7.1%), Industry (+6.9%), Certification (+5.9%), Consumer Products Services (+3.5%), and Agri-Food & Commodities (+2.5%) [11][8] - Negative currency impact of 4.8% due to the euro's appreciation against most currencies [8][11] Financial Position - As of September 30, 2025, the company had net financial debt higher than in June 2025, with over EUR 0.5 billion in available cash and EUR 600 million in undrawn committed credit lines [12] - A EUR 700 million bond was successfully issued with a 3.375% coupon, maturing in October 2033, rated A3 by Moody's [13][12] Strategic Acquisitions - Bureau Veritas signed agreements for two acquisitions in October 2025, expected to generate approximately EUR 32 million in annualized revenue, enhancing its leadership in Buildings & Infrastructure and expanding its Renewables capabilities [6][14] - A total of eight acquisitions have been signed or closed year-to-date, adding EUR 92 million of annualized revenue [6][14] Regional Performance - Revenue growth by region: Europe (+5.2% organically), Asia-Pacific (+8.6% organically), Americas (+1.9% organically), and Africa & Middle East (+15.7% organically) [15] - Strong performance in Southern Europe and France, with double-digit growth in South and Southeast Asia [15] Business Segment Highlights - **Marine & Offshore**: Revenue of EUR 136.6 million, with a strong organic growth of 16.2% driven by new construction and core in-service activities [23][24] - **Agri-Food & Commodities**: Revenue of EUR 284.5 million, with organic growth of 2.5%, supported by strong performance in Metals & Minerals [27][29] - **Industry**: Revenue of EUR 337.7 million, with organic growth of 6.9%, driven by Oil & Gas and Power & Utilities segments [33][35] - **Buildings & Infrastructure**: Revenue of EUR 495.0 million, with organic growth of 7.1%, led by strong demand in the US and Asia-Pacific [41][42] - **Certification**: Revenue of EUR 131.7 million, with organic growth of 5.9%, reflecting strong demand for QHSE & Specialized Schemes solutions [46][48] - **Consumer Products Services**: Revenue of EUR 198.2 million, with organic growth of 3.5%, driven by strong performance in Healthcare and Supply Chain & Sustainability services [52][56]

Core Insights - Bureau Veritas has signed agreements to acquire two companies, Sólida and London Building Control, enhancing its position in the renewables and buildings & infrastructure sectors [2][4] - The acquisitions align with Bureau Veritas' LEAP I 28 strategy, aimed at increasing capability and technical expertise in high-potential markets [3][4] Company Overview - Bureau Veritas is a global leader in Testing, Inspection, and Certification (TIC) services, with a mission to ensure responsible progress and sustainability [5] - The company operates in 140 countries with approximately 84,000 employees, addressing challenges in quality, health and safety, environmental protection, and sustainability [6] Acquisition Details - Sólida specializes in Owner's Engineering, Technical Advisory, and Project Management for renewable energy projects, with a track record of nearly 2,500 projects totaling over 220 GW of renewable capacity [8] - Sólida generated revenues of approximately €18 million in 2024 and employs around 225 professionals [8] - London Building Control is a leading Registered Building Control Approver in the UK, recognized for its services in residential and commercial projects, delivering over 14,000 projects annually [8] - London Building Control generated revenues of approximately €14 million in 2024 and has around 110 employees [8]

REGULATED INFORMATION Courbevoie, France – October 14, 2025 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas Date Number of shares (1) Number of voting rights 30/09/2025 453,911,256 Theoretical number of voting rights: 560,917,087 Number of exercisable voting rights: 550,600,546 (1) including the new shares issued in Euroclear as a result of the exercise of stock options ...

Market Overview - International equities showed mixed results in Q3 2025, with the MSCI EAFE Index rising 4.8%, driven by Asian markets and Canada, while Europe Ex U.K. underperformed [3] - The MSCI Emerging Markets Index advanced 10.6%, supported by a 20.7% rally in China, which constitutes 30% of that benchmark [3] - European markets experienced a slowdown in momentum due to inflation remaining above the European Central Bank's target, with a September reading of 2.2% [4] Economic Conditions - Japan's GDP grew modestly in Q2, aided by tourism, while manufacturing activity remained restrained [5] - The People's Bank of China cut key lending rates in July to address weaknesses in the real estate sector and sluggish consumer demand, with Q2 GDP growth at 5.2% year over year [5] Investment Strategy - The MSCI EAFE Value Index outperformed the MSCI EAFE Growth Index by over 500 basis points in Q3, with value stocks leading growth by more than 1,300 basis points year to date [6] - The ClearBridge International Growth Strategy maintained pace with its core MSCI EAFE benchmark, with sector positioning in IT and financials creating headwinds [12] Company Performance - London Stock Exchange faced a decline due to AI concerns impacting its desktop and data business, while Adyen's revenue missed expectations [13] - Banco Santander was acquired for its streamlined operations and cost-cutting measures, expected to improve profitability [14] - HSBC is well-positioned for growth in Asian wealth management, benefiting from inflows of mainland Chinese money [15] - KBC Group's strong capital position allows for capital distributions or acquisitions, with growing assets under management [16] Sector Contributions - Health care sector saw solid contributions, particularly from European biotechs Argenx and UCB, driven by strong sales and positive clinical trial results [20] - The strategy expanded into the Chinese biotechnology sector with the purchase of WuXi AppTec, known for efficient drug development [21] Portfolio Adjustments - The strategy added 10 positions while exiting 13, with significant purchases in financials and health care, including Prysmian, which is poised for growth in the power cables industry [22] - Softbank trades at a discount to its NAV, holding stakes in key technology companies [23] - Celestica is positioned for growth in AI infrastructure, with expected annual revenue growth of over 20% [24] Outlook - The regions of investment are making progress on growth and equity-friendly policies, with forecasts for double-digit EPS growth in the pan-European Stoxx 600 [27] - Emerging markets are outperforming developed markets, with a focus on China’s growth potential in AI and biotechnology [28][32]

Core Insights - The article discusses the investment position in BVVBY, indicating a beneficial long position through various means such as stock ownership and derivatives [1] Group 1 - The author expresses personal opinions on the investment without receiving compensation from any company mentioned [1] - The article emphasizes the importance of individual due diligence and research before making investment decisions [2] - It highlights that past performance does not guarantee future results, and no specific investment recommendations are provided [3]

Core Insights - The article discusses the investment potential of BVVBY shares, highlighting a beneficial long position held by the author [1]. Group 1 - The author expresses a personal opinion on the stock without receiving compensation, indicating a level of independence in the analysis [1]. - There is an emphasis on the necessity for investors to conduct their own due diligence and research before making investment decisions [2]. - The article notes that past performance does not guarantee future results, underscoring the inherent uncertainties in investment [3].

Group 1 - Bureau Veritas successfully completed a bond issuance of EUR 700 million, maturing in October 2033, with a coupon rate of 3.375% [2][3] - The bond issuance was oversubscribed by 2.4 times, indicating strong investor confidence in Bureau Veritas' business model and credit profile [3] - The bond will be rated A3 by Moody's, reflecting the company's solid credit standing [3] Group 2 - The new bond issuance is part of Bureau Veritas' LEAP | 28 strategy, aimed at leveraging favorable market conditions for general corporate purposes [3] - Admission of the bonds to trading on Euronext Paris is expected to take place on October 1, 2025 [4] - Crédit Agricole CIB and Natixis served as Global Coordinators and Active Joint Bookrunners for the bond issuance [4] Group 3 - Bureau Veritas is a global leader in testing, inspection, and certification services, with a mission to ensure responsible progress and sustainability [5][6] - The company has a workforce of 84,000 employees operating in 140 countries, addressing challenges in quality, health and safety, environmental protection, and sustainability [6] - Bureau Veritas is listed on Euronext Paris and is part of the CAC 40 and CAC 40 ESG indices [7]

Core Viewpoint - Wendel successfully completed the accelerated placement of approximately 23.3 million Bureau Veritas shares, raising around 591 million euros to prepare for the settlement of an exchangeable bond maturing in March 2026 [1][2][4]. Group 1: Transaction Details - The sale was executed through an accelerated bookbuilding process aimed at qualified and international institutional investors, with a share price set at 25.40 euros [2][3]. - The proceeds from the placement will reduce Wendel's Loan-To-Value (LTV) ratio to approximately 13%, enhancing its financial flexibility ahead of the bond's maturity [4]. Group 2: Impact on Shareholding - Following the placement, Wendel's stake in Bureau Veritas decreased from 26.5% of the share capital and 41% of voting rights to about 21.4% of the share capital and 35% of voting rights [5]. - Wendel has committed to a lock-up period of 180 calendar days for its remaining Bureau Veritas shares post-placement [5]. Group 3: Market Context - The transaction was strategically timed due to the short period until the bond's maturity, upcoming negative windows constraints, and favorable market conditions [4]. - The placement was led by BNP PARIBAS and Goldman Sachs Bank Europe SE, with Société Générale also participating as a joint bookrunner [6].

Core Viewpoint - Wendel is launching the accelerated placement of approximately 23.3 million Bureau Veritas shares to prepare for the settlement of an exchangeable bond maturing in March 2026, aiming to enhance financial flexibility and reduce its Loan-To-Value ratio ahead of the bond's maturity [1][4]. Group 1: Transaction Details - The exchangeable bond (EB) was issued in March 2023, raising €750 million with an annual coupon of 2.625%, which is lower than a straight bond due to its optional component [2]. - The transaction involves monetizing the underlying shares of the EB and implementing a symmetrical hedging protection to neutralize the optional component, with BNP PARIBAS and Goldman Sachs acting as hedging counterparties [3]. - Approximately 2.3 million shares will be ordered by the hedging counterparties as part of the placement, which will be fully allocated by Wendel [3]. Group 2: Financial Implications - The proceeds from the placement will help reduce Wendel's Loan-To-Value ratio, allowing the company to pursue its strategic plan more effectively [4]. - Following the placement, Wendel's stake in Bureau Veritas will decrease from 26.5% of the share capital and 41% of voting rights to approximately 21.4% of the share capital and 35% of voting rights [5]. Group 3: Market and Regulatory Context - The placement is reserved for qualified investors and international institutional investors, and it is not a public offering in any country, including France [7][10]. - The final terms of the placement will be announced after the completion of the bookbuilding process, which is expected to settle on September 18, 2025 [6].

Group 1: Market Reaction - Despite Fitch Ratings lowering France's long-term credit rating, the French stock market is showing positive movement, with investors anticipating policy announcements from major central banks this week [1] - The benchmark CAC 40 index increased by 95.78 points or 1.23%, reaching 7,921.02 [2] Group 2: Company Performance - Kering's stock rose more than 4%, while Thales increased nearly 4% [2] - STMicroElectronics and Societe Generale saw gains of 3.1% and 2.85%, respectively [2] - Other notable companies such as Credit Agricole, L'Oreal, LVMH, and Airbus experienced increases between 2% to 2.2% [2] - A broader range of companies including BNP Paribas, Bouygues, Stellantis, and TotalEnergies saw stock increases between 1% to 1.8% [2] Group 3: Economic Indicators - The euro area trade surplus decreased to EUR 12.4 billion in July from EUR 18.5 billion the previous year, although it was above June's level of EUR 8 billion [4] - Annual export growth slowed to 0.4% in July from 0.8% in June, while imports rose by 3.1% [4] - The decline in trade surplus was primarily attributed to chemicals and related products, which saw a surplus drop to EUR 17.4 billion from EUR 23.8 billion [5]